Skip to main content
Equibles
REGN $758.27 +1.03%
REGN logo
REGN · Regeneron Pharmaceuticals, Inc.
Track REGN — free

Use REGN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research REGN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$758.27 +7.76 (+1.03%) At close · Sep 30
S&P 500 member Nasdaq-100 member Russell 1000 member Rebalance outlook locked
Market Cap
$81.13B
Shares
102.95M
Volume · Sep 30 872.46K Avg daily vol (3M) 755.8K
All earnings calls

Earnings call · FY2026 Q3

Regeneron Pharmaceuticals, Inc. (REGN) Q3 2026 Earnings Call

Scheduled Oct 30, 2026
Oct 30, 2026 0 turns
Period
FY2026 Q3
Runtime
—
Sources
0 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Event details are collected in one workspace.

Research coverage

0 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Company webcastOpen the original investor-relations page
Full-screen source Call document

REGN transcript alerts

Regeneron Pharmaceuticals, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →